The goal of the Covid-19 Testing Industry Consortium is to inform, improve, innovate, and accelerate various aspects of testing, ranging from research to clinical diagnostic applications.
Read More
The addition of new, rapid point-of-care platforms will expand national testing options.
Read More
BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season.
Read More
The assay is now authorized for asymptomatic individuals and symptomatic sample pooling.
Read More
One lab that participated in NILA’s survey reports having enough reagent to process 500 tests per day, yet their covid-19 testing capacity is at least 3,000 tests per day.
Read More